Neutrophil Gelatinase-associated Lipocalin as a New Biomarker to Detect Acute Kidney Injury in Postoperative Cardiac Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier:
NCT01594788
First received: May 7, 2012
Last updated: May 8, 2012
Last verified: January 2012
  Purpose

Observational study aimed to test the ability of Neutrophil Gelatinase-associated Lipocalin (NGAL) concentration in blood and urine to predict and diagnose early acute renal failure (ARF) in patients after cardiac surgery with/without Cardiopulmonary bypass (CPB).


Condition
Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: NGAL as a Marker of Acute Kidney Injury After Cardiac Surgery. Observational Study

Resource links provided by NLM:


Further study details as provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau:

Estimated Enrollment: 340
Study Start Date: April 2011
Estimated Study Completion Date: December 2012
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Hospitalised patients

Criteria

Inclusion Criteria:

  • Men or women over 18 years proposed for cardiac surgery with / without CPB.
  • Accepting to participate in the study, with informed consent signed by the patient, guardian or family member.

Exclusion Criteria:

  • Patients < 18 years.
  • Patients do not agree to participate in the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01594788

Contacts
Contact: Mercedes Garcia, MD +34 93 553 75 41 mgarciaa@santpau.cat

Locations
Spain
Hospital de la Santa Creu i Sant Pau Recruiting
Barcelona, Spain, 08025
Contact: Mercedes Garcia, MD    +34 93 553 75 41    mgarciaa@santpau.cat   
Principal Investigator: Mercedes Garcia, MD         
Sponsors and Collaborators
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  More Information

No publications provided

Responsible Party: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier: NCT01594788     History of Changes
Other Study ID Numbers: IIBSP-NGL-2011-04
Study First Received: May 7, 2012
Last Updated: May 8, 2012
Health Authority: Spain: Comité Ético de Investigación Clínica

Additional relevant MeSH terms:
Acute Kidney Injury
Kidney Diseases
Renal Insufficiency
Urologic Diseases

ClinicalTrials.gov processed this record on October 23, 2014